Sale!

SNTA1 Gene Long QT syndrome type 12 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SNTA1 gene, associated with Long QT Syndrome Type 12 (LQT12), plays a crucial role in the electrical activity of the heart, influencing how the heart beats. Mutations in the SNTA1 gene can disrupt the heart’s rhythm, leading to Long QT Syndrome, a condition characterized by prolonged heartbeats seen on an electrocardiogram. This can increase the risk of fainting, seizures, and sudden death, especially under stress or during exercise.

To identify mutations in the SNTA1 gene, a genetic test is available at DNA Labs UAE. This test is crucial for diagnosing LQT12, guiding treatment options, and determining the need for lifestyle adjustments or interventions to prevent potentially life-threatening cardiac events. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for mutations in the SNTA1 gene.

The cost of the SNTA1 Gene Long QT Syndrome Type 12 Genetic Test at DNA Labs UAE is 4400 AED. This investment in health can provide invaluable information for individuals and families affected by or at risk of LQT12, enabling proactive management and care for this serious condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SNTA1 Gene Long QT syndrome type 12 Genetic Test

Welcome to DNA Labs UAE, where we offer the SNTA1 Gene Long QT syndrome type 12 Genetic Test at a cost of AED 4400.0. This test is specifically designed to diagnose Long QT syndrome type 12 (LQT12), a rare genetic disorder that affects the electrical activity of the heart.

Test Details

The SNTA1 gene is associated with LQT12, which is characterized by prolonged QT intervals on electrocardiograms (ECGs) and can lead to potentially life-threatening arrhythmias. Our Next-Generation Sequencing (NGS) technology allows for the simultaneous analysis of multiple genes, including the SNTA1 gene, to identify any mutations or variations that may be responsible for the development of LQT12.

Test Components and Price

  • Test Name: SNTA1 Gene Long QT syndrome type 12 Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: AED 4400.0

Sample Condition and Report Delivery

We require a blood sample or extracted DNA for this test. Alternatively, one drop of blood on an FTA Card can also be used. The report will be delivered within 3 to 4 weeks.

Test Method and Type

We use NGS technology for the SNTA1 Gene Long QT syndrome type 12 Genetic Test. This method allows for efficient and accurate sequencing of the DNA to identify any mutations or variations in the SNTA1 gene.

The test type is specifically focused on Cardiovascular Pneumology Disorders and is conducted by our expert Cardiologists in our Genetics Test Department.

Pre Test Information

Prior to undergoing the SNTA1 Gene Long QT syndrome type 12 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with LQT12 and to discuss the implications of the SNTA1 gene.

Interpreting the Results

It is crucial to note that genetic testing for Long QT syndrome, including LQT12, should be performed in specialized genetic testing laboratories. The test should be ordered by a healthcare professional with expertise in genetics or cardiology. The results of the genetic test should be interpreted by a qualified healthcare professional who can provide appropriate counseling and guidance based on the specific genetic findings.

At DNA Labs UAE, we prioritize accuracy and quality in our genetic testing services. Our SNTA1 Gene Long QT syndrome type 12 Genetic Test can provide important information for the diagnosis, treatment, and management of LQT12. Contact us today to schedule an appointment or to learn more about our services.

Test Name SNTA1 Gene Long QT syndrome type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SNTA1 Gene Long QT syndrome type 12 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SNTA1 Gene Long QT syndrome type 12 NGS Genetic DNA Test gene SNTA1
Test Details

The SNTA1 gene is associated with Long QT syndrome type 12 (LQT12), which is a rare genetic disorder that affects the electrical activity of the heart. LQT12 is characterized by prolonged QT intervals on electrocardiograms (ECGs), which can lead to potentially life-threatening arrhythmias.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of Long QT syndrome, NGS testing can be used to identify mutations or variations in the SNTA1 gene that may be responsible for the development of LQT12.

The NGS genetic test for LQT12 typically involves obtaining a DNA sample from the individual, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology, which can identify any mutations or variations in the SNTA1 gene. These results can help in the diagnosis of LQT12 and may also provide important information for treatment and management of the condition.

It’s important to note that genetic testing for Long QT syndrome, including LQT12, is typically performed in specialized genetic testing laboratories and is usually ordered by a healthcare professional with expertise in genetics or cardiology. The results of the genetic test should be interpreted by a qualified healthcare professional who can provide appropriate counseling and guidance based on the specific genetic findings.